Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272)
Incyte Corporation
Incyte Corporation
Sierra Oncology LLC - a GSK company
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Mayo Clinic
National Cancer Institute (NCI)
H. Lee Moffitt Cancer Center and Research Institute
Baylor College of Medicine
OHSU Knight Cancer Institute
Mayo Clinic